Literature DB >> 21422848

Second-trimester abortion for fetal anomalies or fetal death: labor induction compared with dilation and evacuation.

Amy G Bryant1, David A Grimes, Joanne M Garrett, Gretchen S Stuart.   

Abstract

OBJECTIVE: To compare the safety and effectiveness of dilation and evacuation (D&E) and labor-induction abortion performed for fetal anomalies or fetal death in the second trimester.
METHODS: We performed a retrospective cohort study of second-trimester abortions performed for fetal indications. We compared the frequency of complications and effectiveness of abortions performed at 13-24 weeks for these indications. We calculated proportions of patients with complications for these two methods and controlled for confounding using a log binomial model.
RESULTS: Labor-induction abortions had higher complication rates and lower effectiveness than did D&E. Thirty-two of 136 women undergoing labor induction (24%) experienced one or more complications, in contrast to 9 of 263 women (3%) undergoing D&E (unadjusted relative risk 6.9 [95% confidence interval 3.4-14.0]). When controlled for confounding, the adjusted risk ratio for labor induction was 8.5 (95% confidence interval 3.7-19.8) compared with D&E.
CONCLUSION: Dilation and evacuation is significantly safer and more effective than labor induction for second-trimester abortion for fetal indications. Bias and chance are unlikely explanations for these large discrepancies. Women facing this difficult decision should be offered a choice of methods and be provided information about their comparative safety and effectiveness. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2011        PMID: 21422848     DOI: 10.1097/AOG.0b013e31820c3d26

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

1.  Second trimester termination of pregnancy.

Authors:  Athol Kent
Journal:  Rev Obstet Gynecol       Date:  2011

2.  An exploration of the prevalence and patterns of care for women presenting with mid-trimester loss.

Authors:  S Cullen; S Power; B Coughlan; J Chaney; M Butler; M Brosnan
Journal:  Ir J Med Sci       Date:  2016-02-09       Impact factor: 1.568

3.  Induction of labor compared to dilation and evacuation for postmortem analysis.

Authors:  A K Lal; M A Kominiarek; N M Sprawka
Journal:  Prenat Diagn       Date:  2014-03-18       Impact factor: 3.050

4.  Surgical and medical second trimester abortion in South Africa: a cross-sectional study.

Authors:  Daniel Grossman; Deborah Constant; Naomi Lince; Marijke Alblas; Kelly Blanchard; Jane Harries
Journal:  BMC Health Serv Res       Date:  2011-09-19       Impact factor: 2.655

5.  Comparison of Dilapan-S and laminaria for cervical priming before surgical pregnancy termination at 17-22 weeks' gestation.

Authors:  Dennis G Chambers; Robin J Willcourt; Anthony R Laver; Jane K Baird; Wye Y Herbert
Journal:  Int J Womens Health       Date:  2011-10-20

6.  Comparison of surgical versus medical termination of pregnancy between 13-20 weeks of gestation in Ethiopia: A quasi-experimental study.

Authors:  Tesfaye Hurissa Tufa; Sarah Prager; Mekitie Wondafrash; Shikur Mohammed; Nicole Byl; Jason Bell
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

7.  Fetal diagnostic indications for second and third trimester outpatient pregnancy termination.

Authors:  Warren M Hern
Journal:  Prenat Diagn       Date:  2014-02-27       Impact factor: 3.050

Review 8.  Medical regimens for abortion at 12 weeks and above: a systematic review and meta-analysis.

Authors:  Katherine Whitehouse; Ashley Brant; Marita Sporstol Fonhus; Antonella Lavelanet; Bela Ganatra
Journal:  Contracept X       Date:  2020-08-20

9.  Introducing the Dilation and Evacuation Technique in Brazil: Lessons Learned From an International Partnership to Expand Options for Brazilian Women and Girls.

Authors:  Bianca M Stifani; Susane Mei Hwang; Renata Rodrigues Catani; Helena Borges Martins da Silva Paro; Nerys Benfield
Journal:  Front Glob Womens Health       Date:  2022-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.